Articles from AleraCare
AleraCare, a leading provider of infusion and specialty pharmacy services across the U.S., and Pure Healthcare, a leading national medical group that delivers healthcare services for individuals with complex chronic conditions such as rheumatoid arthritis, Crohn's disease, multiple sclerosis, Alzheimer's disease and other autoimmune conditions, today announced the completion of their previously announced merger.
By AleraCare · Via Business Wire · November 24, 2025
AleraCare, a leading provider of infusion and specialty pharmacy services across the U.S., today announced that its Board of Directors has unanimously appointed Joseph Cosgrove as the company’s new Chief Executive Officer and as a member of the Board. Russ Corvese will retire as Chief Executive Officer, effective October 13, 2025, and will serve as an advisor to the business during the transition.
By AleraCare · Via Business Wire · October 8, 2025
AleraCare, a leading provider of infusion and specialty pharmacy services across the U.S., and PURE Healthcare, a leading national medical group that delivers healthcare services for individuals with complex chronic conditions such as rheumatoid arthritis, Crohn's disease, multiple sclerosis, Alzheimer's disease and other autoimmune conditions, today announced that the businesses have entered into a definitive merger agreement. Terms of the transaction were not disclosed.
By AleraCare · Via Business Wire · August 13, 2025

AleraCare, (the “Company”) a leading provider of infusion treatments and pharmacy services for high-need and medically complex populations, today announced that it has launched a rebranding of the Company. The Company’s existing healthcare companies: MedicoRx Specialty Pharmacy, Vasco Infusion, VascoRx Specialty Pharmacy and Vasco Compounding have been consolidated under the AleraCare brand name.
By AleraCare · Via Business Wire · May 1, 2023